162 related articles for article (PubMed ID: 856237)
21. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
Sheldon PW; Hill SA; Foster JL; Fowler JF
Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
[TBL] [Abstract][Full Text] [Related]
22. Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.
Sheldon PW; Hill SA
Br J Cancer; 1977 Aug; 36(2):198-205. PubMed ID: 911657
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Brown JM; Yu NY; Workman P
Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
[TBL] [Abstract][Full Text] [Related]
24. [Cancer and radiotherapy. (4). Hypoxic cell sensitizers and hyperthermia combined with radiation in cancer treatment].
Abe M; Takahashi M; Ono K; Hiraoka M
Iyodenshi To Seitai Kogaku; 1982 Jun; 20(3):203-9. PubMed ID: 6759728
[No Abstract] [Full Text] [Related]
25. Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.
Stratford IJ; Adams GE
Br J Cancer; 1977 Mar; 35(3):307-13. PubMed ID: 856238
[TBL] [Abstract][Full Text] [Related]
26. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
Honess DJ; Wasserman TH; Workman P; Ward R; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028
[TBL] [Abstract][Full Text] [Related]
27. The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582.
Denekamp J; Morris C; Field SB
Radiat Res; 1977 May; 70(2):425-32. PubMed ID: 860014
[No Abstract] [Full Text] [Related]
28. Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in mice.
Walton MI; Bleehen NM; Workman P
Br J Cancer; 1989 May; 59(5):667-73. PubMed ID: 2736198
[TBL] [Abstract][Full Text] [Related]
29. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
Hofer KG; Lakkis M; Hofer MG
Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
[TBL] [Abstract][Full Text] [Related]
30. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.
Teicher BA; Kowal CD; Kennedy KA; Sartorelli AC
Cancer Res; 1981 Mar; 41(3):1096-9. PubMed ID: 7459853
[TBL] [Abstract][Full Text] [Related]
31. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.
Brown JM; Yu NY; Cory MJ; Bicknell RB; Taylor DL
Br J Cancer Suppl; 1978 Jun; 3():206-11. PubMed ID: 277229
[TBL] [Abstract][Full Text] [Related]
32. Combined effects of misonidazole, microwave hyperthermia, and X-rays on the in vivo sister chromatid exchanges and chromosomal abnormalities of the dbrB tumor and on the survival of its host.
Banerjee R; Goldfeder A; Mitra J
Cancer Res; 1983 May; 43(5):2210-5. PubMed ID: 6831443
[TBL] [Abstract][Full Text] [Related]
33. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
[TBL] [Abstract][Full Text] [Related]
34. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
[No Abstract] [Full Text] [Related]
35. The hyperthermic potentiation of the cytotoxic effect of misonidazole on the EMT6 mouse tumour: relevance of in vitro measurement of in vivo effect.
Honess DJ; Morgan JE; Bleehen NM
Br J Cancer Suppl; 1978 Jun; 3():173-7. PubMed ID: 277221
[TBL] [Abstract][Full Text] [Related]
36. The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice.
Walton MI; Bleehen NM; Workman P
Br J Cancer; 1987 May; 55(5):469-76. PubMed ID: 3606940
[TBL] [Abstract][Full Text] [Related]
37. Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration.
Hill SA; Fowler JF; Minchinton AI; Stratford MR; Denekamp J
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Aug; 44(2):143-50. PubMed ID: 6603435
[TBL] [Abstract][Full Text] [Related]
38. Bioluminescence imaging of metabolites in a human tumour xenograft after treatment with hyperthermia and/or the radiosensitizer pimonidazole.
Tamulevicius P; Streffer C
Int J Hyperthermia; 1997; 13(2):235-45. PubMed ID: 9147149
[TBL] [Abstract][Full Text] [Related]
39. The effect of an hypoxic cell sensitizer on tumour growth delay and cell survival. Implications for cell survival in situ and in vitro.
McNally NJ
Br J Cancer; 1975 Nov; 32(5):610-8. PubMed ID: 1212418
[TBL] [Abstract][Full Text] [Related]
40. Developments in radiotherapy other than heavy particle beams.
Fowler JF
Int J Radiat Oncol Biol Phys; 1977; 3():351-8. PubMed ID: 207661
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
